Optimizing vaccine design for cellular processing, MHC binding and TCR recognition (Q35005969)

5 August 2017

1 reference

title

Optimizing vaccine design for cellular processing, MHC binding and TCR recognition (English)

1 reference

5 August 2017

1 reference

4

McKinney D

1 reference

5 August 2017

Sette A

1

1 reference

5 August 2017

Newman M

2

1 reference

5 August 2017

Livingston B

3

1 reference

5 August 2017

Sidney J

5

1 reference

5 August 2017

Ishioka G

6

1 reference

5 August 2017

Tangri S

7

1 reference

5 August 2017

Alexander J

8

1 reference

5 August 2017

Fikes J

9

1 reference

5 August 2017

Chesnut R

10

1 reference

5 August 2017

1 June 2002

1 reference

5 August 2017

1 reference

5 August 2017

59

1 reference

5 August 2017

6

1 reference

5 August 2017

443-451

1 reference

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

5 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Two complementary methods for predicting peptides binding major histocompatibility complex molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Peptide binding to MHC class I molecules: implications for antigenic peptide prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590601.X

7 January 2021

10.1034/J.1399-0039.2002.590601.X

Identifiers

DOI

1 reference

5 August 2017

1 reference